Wed, June 18, 2025
Tue, June 17, 2025
Mon, June 16, 2025
Sun, June 15, 2025
Sat, June 14, 2025
Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025

Novo Nordisk overtakes SAP as Europe's most valuable company

  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. takes-sap-as-europe-s-most-valuable-company.html
  Print publication without navigation Published in Business and Finance on by Fortune
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
  Novo's market capitalization reached $365 billion, slightly surpassing SAP's valuation of $364.3 billion.


Novo Nordisk has surpassed SAP to become Europe's most valuable company, with a market capitalization of $600 billion compared to SAP's $220 billion. This shift is attributed to the soaring demand for Novo Nordisk's weight-loss and diabetes drugs, Wegovy and Ozempic, which have seen significant success in the U.S. market. The company's stock has risen by 50% over the past year, reflecting strong investor confidence in its growth potential. Meanwhile, SAP, a leader in enterprise software, has experienced slower growth, contributing to its decline in market value relative to Novo Nordisk.

Read the Full Fortune Article at:
[ https://fortune.com/europe/2025/06/13/novo-nordisk-overtakes-sap-europe-most-valuable-company/ ]